21 completed, 3 terminated, 3 unknown, 3 withdrawn. 36 Phase 1, 16 Phase 2.
Follow Hypoxia, Brain: new trials by email Literature Review of Hypoxia, Brain trials Research Report on Hypoxia, Brain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy Wharton's jelly-derived mesenchymal stem cells, 0.9 % Normal Saline - Hypoxic-Ischemic Encephalopathy, Neonatal, Brain Injuries, Hypoxic-Ischemic | Phase 1 / Phase 2 | Not yet recruiting | Mahidol University | 40 | 2026-09-15 | 2026-09-02 |
| Hydrogen In Neonatal Encephalopathy (HIE) Trial Hydrogen Gas (H2) - HIE, Hypoxic-Ischemic Encephalopathy | Phase 1 | Not yet recruiting | Boston Children's Hospital | 54 | 2026-03-01 | 2026-02-17 |
| A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury Metformin - Hypoxic-Ischemic Encephalopathy, HIE | Phase 1 | Enrolling by invitation | Boston Children's Hospital | 30 | 2025-10-01 | 2026-02-17 |
| Dose Optimization of Caffeine for HIE Caffeine citrate 20 mg/kg, Caffeine citrate 30 mg/kg - Hypoxic-Ischemic Encephalopathy | Phase 1 | Active not recruiting | University of North Carolina, Chapel Hill | 16 | 2024-07-26 | 2026-08-14 |
| PK and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia Caffeine citrate - Acute Kidney Injury, Hypoxic-Ischemic Encephalopathy | Phase 1 | Withdrawn | University of Arkansas | 2024-05-08 | 2024-05-10 | |
| Metformin Treatment in Infants After Perinatal Brain Injury Metformin Hydrochloride - Hypoxic Ischemic Encephalopathy of Newborn, Premature Birth | Phase 1 | Terminated | The Hospital for Sick Children | 1 | 2023-05-02 | 2024-03-07 |
| Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia Drug Lowering Cerebral Blood Flow (CBF) and Normoxia Sleep, Drug Lowering CBF and Intermittent Hypoxia Sleep, Placebo and Normoxia Sleep - Obstructive Sleep Apnea of Adult, Hypoxia, Brain | Phase 1 / Phase 2 | Recruiting | University of Calgary | 12 | 2023-01-01 | 2026-05-01 |
| Multiple N-of-1 Trials of (Intermittent) Hypoxia Therapy in Parkinson's Disease Hypoxic Gas Mixture - Parkinson Disease, Effect of Drug | Phase 1 / Phase 2 | Completed | Radboud University Medical Center | 29 | 2022-02-22 | 2023-07-21 |
| Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness Methylphenidate - Brain Injury Traumatic Severe (Diagnosis), Coma | Phase 1 | Active not recruiting | Massachusetts General Hospital | 10 | 2020-08-24 | 2025-10-29 |
| The Clinical Trial of CL2020 Cells for Neonatal Hypoxic Ischemic Encephalopathy CL2020 cells - Hypoxia-Ischemia, Brain | Phase 1 | Completed | Nagoya University | 9 | 2020-03-04 | 2023-10-03 |
| A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy HB-adMSCs - Traumatic Brain Injury | Phase 1 / Phase 2 | Completed | Hope Biosciences LLC | 24 | 2020-01-01 | 2026-11-09 |
| Caffeine for Hypoxic-Ischemic Encephalopathy Caffeine Citrate 5 mg/kg, Caffeine Citrate 10 mg/kg - Hypoxic-Ischemic Encephalopathy | Phase 1 | Completed | University of North Carolina, Chapel Hill | 17 | 2019-08-14 | 2025-03-27 |
| Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE Infusion of hCT-MSC - Moderate to Severe Hypoxic-ischemic Encephalopathy | Phase 1 | Completed | Joanne Kurtzberg, MD | 6 | 2018-12-27 | 2024-04-12 |
| Feasibility and Safety of Umbilical Cord Blood Transfusion in the Treatment of Neonatal Cerebral Ischemia and Anemia autologous umbilical cord blood (UCB), standard care - Hypoxic-Ischemic Encephalopathy, Hypoxia Neonatal | Phase 1 | Unknown | Mononuclear Therapeutics Ltd. | 40 | 2018-04-16 | 2018-06-07 |
| Sildenafil Administration to Treat Neonatal Encephalopathy Sildenafil, Ora-Blend - Neonatal Encephalopathy | Phase 1 | Completed | McGill University Health Centre/Research Institute of the McGill University Health Centre | 28 | 2016-07-01 | 2022-02-08 |
| TIBOHCA: Safety, Tolerability and Pharmacokinetics of 2-Iminobiotin (2-IB) After OHCA 2-Iminobiotin - Cardiac Arrest, Hypoxic Ischemic Brain Injury | Phase 1 / Phase 2 | Terminated | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 21 | 2016-05-01 | 2021-02-18 |
| Hypoxic-Ischemic Encephalopathy Therapy Optimization in Neonates for Better Neuroprotection With Inhalative CO2 5% carbon-dioxide inhalation - Hypoxic-Ischaemic Encephalopathy, Perinatal Asphyxia | Phase 1 | Completed | Semmelweis University | 10 | 2016-02-01 | 2021-04-26 |
| Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy Autologous cord blood, Hypothermia - Hypoxic Ischemic Encephalopathy, Cerebral Infarction | Phase 1 / Phase 2 | Withdrawn | Children's Hospital of Fudan University | 2015-09-08 | 2023-12-29 | |
| Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy Autologous umbilical cord blood cells - Neonatal Encephalopathy, Hypoxic-ischemic Encephalopathy | Phase 1 | Completed | Neonatal Encephalopathy Consortium, Japan | 6 | 2014-08-01 | 2019-10-29 |
| Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy Melatonin, placebo - Newborn Hypoxic Ischemic Encephalopathy | Phase 1 | Withdrawn | St. Louis University | 2014-04-01 | 2015-07-03 |
Showing 20 of 36. Sign in to see all of them.
Hypoxia-Ischemia, Brain (34) · Asphyxia Neonatorum (5) · Brain Injuries (3) · Hypothermia (3) · Asphyxia (2) · Intracranial Hemorrhages (2) · Stroke (2) · Acute Kidney Injury (1) · Anemia, Neonatal (1) · Brain Injuries, Traumatic (1) · Bronchiolitis Obliterans Syndrome (1) · Cerebral Infarction (1) · Cerebral Palsy (1) · Coma (1)
Brain Diseases (36) · Central Nervous System Diseases (36) · Nervous System Diseases (36) · Pathological Conditions, Signs and Symptoms (36) · Signs and Symptoms (36) · Signs and Symptoms, Respiratory (36) · Cardiovascular Diseases (35) · Cerebrovascular Disorders (35) · Hypoxia (35) · Vascular Diseases (35) · Brain Ischemia (34) · Pathologic Processes (6) · Wounds and Injuries (6) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)
Saline Solution (3) · caffeine citrate (3) · Bumetanide (2) · Epoetin Alfa (2) · Erythropoietin (2) · Metformin (2) · 2-iminobiotin (1) · 5,10-dihydro-5-methylphenazine (1) · Cerebrovascular Circulation (1) · Clonidine (1) · Cool-Down Exercise (1) · Core Binding Factors (1) · Darbepoetin alfa (1) · Endothelium-Dependent Relaxing Factors (1) · Hypothermia, Induced (1)
Boston Children's Hospital (2) · University of California, San Francisco (2) · University of North Carolina, Chapel Hill (2) · Zhengzhou University (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Children's Hospital of Fudan University (1) · Great Ormond Street Hospital for Children NHS Foundation Trust (1) · Hebei Medical University (1) · Hope Biosciences LLC (1) · Joanne Kurtzberg, MD (1) · Johns Hopkins University (1) · Kristin R Hoffman (1) · Mahidol University (1) · Massachusetts General Hospital (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1)
United States (16) · China (4) · Canada (3) · Netherlands (3) · Japan (2) · United Kingdom (2) · Egypt (1) · Hong Kong (1) · Hungary (1) · India (1) · Ireland (1) · Singapore (1) · Sweden (1) · Thailand (1)
Brian Kalish, MD (2) · Changlian Zhu, MD, PhD (2) · Wesley M Jackson, MD, MPH (2) · Yvonne W Wu, MD, MPH (2) · Balraj Guhan, MD (1) · Baoyong Yan, Doctor (1) · Brian L Edlow, MD (1) · Brian T Kalish, MD (1) · Charles M Cotten, MD MHS (1) · Charles S Cox, MD (1) · Cheo Lian Yeo, MBBS (1) · Estelle B Gauda, MD (1) · Farouk Sadiq, MD (1) · Haruo Shintaku, MD, PhD (1) · Janet Soul, MD,CM (1)
PMID 24524452, PMID 15199405, PMID 19172693, PMID 19883750, PMID 20385632, PMID 20631189, PMID 23008465, PMID 23133515, PMID 24388332, PMID 25439577, PMID 25765333, PMID 25794112, PMID 27535166, PMID 27632779, PMID 28949952, PMID 29016557, PMID 29769612, PMID 30661082, PMID 31261373, PMID 32813884, PMID 33362471, PMID 34482377, PMID 35473726, PMID 35836147, PMID 37199820, PMID 37422495, PMID 37587184, PMID 38142044, PMID 38902120, PMID 39401019, PMID 39498807, PMID 40850908
DP2HD101400 (1), K23HD111623 (1), R01NS066929 (1)